American Shared Hospital Services (AMS)
XASE:AMS
Want to see AMS full AI Analyst Report?
Top Page
American Shared Hospital Services
(NYSE MKT:AMS)
Select Model
Select Model
Rating:48Neutral
Price Target:
$1.50
▼(-28.57% Downside)
Action:Reiterated
Date:05/15/26
The score is held down primarily by weak financial performance (recent losses and negative/volatile free cash flow) and bearish technical positioning (below key moving averages). These are partially offset by a constructive earnings update showing improving revenue, EBITDA and margins, and better liquidity/leverage progress, though valuation support is limited due to the negative P/E and no dividend yield.
Positive Factors
Utilization-driven Revenue Growth
Sustained double-digit top-line growth driven by utilization indicates structural demand for high-end oncology services. Higher procedure volumes (including proton fractions +20%+) should allow fixed-cost absorption, support margin expansion as centers scale, and create a multi-quarter runway for recurring revenue.
Negative Factors
Continued GAAP Losses
Persistent GAAP losses indicate operations have not yet converted growth into sustainable profitability. Continued negative net income undermines return metrics, may constrain reinvestment capacity, and increases reliance on external financing until centers achieve steady-state margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Utilization-driven Revenue Growth
Sustained double-digit top-line growth driven by utilization indicates structural demand for high-end oncology services. Higher procedure volumes (including proton fractions +20%+) should allow fixed-cost absorption, support margin expansion as centers scale, and create a multi-quarter runway for recurring revenue.
Read all positive factors
American Shared Hospital Services (AMS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$8.94M
Dividend YieldN/A
Average Volume (3M)78.93K
Price to Earnings (P/E)―
Beta (1Y)0.29
Revenue Growth-0.62%
EPS Growth-200.79%
CountryUS
Employees81
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.23
Shares Outstanding6,625,000
10 Day Avg. Volume41,017
30 Day Avg. Volume78,931
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.50
P/FCF Ratio>-0.01
Enterprise Value/Market Cap2.78
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit4.62
Enterprise Value/Ebitda6.57
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.03
Revenue Forecast (FY)$29.73M
American Shared Hospital Services Business Overview & Revenue Model
Company Description
American Shared Hospital Services (AMS) is a leading provider of advanced medical equipment and services to healthcare facilities across the United States. The company specializes in offering cutting-edge technologies in the field of radiation the...
How the Company Makes Money
AMS makes money primarily by providing hospitals with access to expensive, specialized medical technology through shared-services and similar arrangements, rather than hospitals purchasing and operating all equipment entirely on their own. Under t...
American Shared Hospital Services Earnings Call Summary
Earnings Call Date:May 14, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 19, 2026
Earnings Call Sentiment Positive
The call presented meaningful operational and financial improvements: double-digit top-line growth (+15.9%), strong expansion in the direct patient services segment (+30.2%), adjusted EBITDA growth (+18.4%), improved gross margins (+44% in dollars) and a stronger cash position. These positives are tempered by an ongoing GAAP net loss ($0.6M), higher operating and maintenance costs associated with ramping centers, and continuing lender discussions and multi-year timelines for major projects. On balance, the company demonstrated clear operational momentum and improving financial metrics, while still managing near-term cost and financing execution risks.Positive Updates
Revenue Growth
Total revenue increased 15.9% year over year to $7.1M (from $6.1M), driven by stronger utilization across the network.
Negative Updates
Continued Net Loss
Company remains unprofitable on a GAAP basis with net loss attributable to the company of $0.6M (loss per diluted share $0.09) though improved from prior-year loss of $0.10 per share.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth
Total revenue increased 15.9% year over year to $7.1M (from $6.1M), driven by stronger utilization across the network.
Read all positive updates
Company Guidance
Management offered directional guidance rather than specific forward numbers, saying volumes are trending positively into Q2 and that continued revenue and margin expansion is expected as utilization scales; they reiterated plans for Guadalajara to begin operations late this year, a Bristol radiation therapy center in ~18–24 months and a Johnston proton center in ~24–30 months, and noted ongoing lender discussions. They pointed to Q1 results as the basis for that outlook: total revenue +15.9% to $7.1M (Direct Patient Care $4.1M, +30.2%; Leasing ≈ $3.0M), adjusted EBITDA +18.4% to $1.1M, gross margin +44% to $1.3M (18.2% vs 15.4%), proton fractions +20%+ YoY, total cost of revenue $5.8M (from $5.2M), SG&A $1.9M, operating loss improved to $(0.9)M (from $(1.3)M), net loss $(0.6)M or $0.09/diluted (vs $0.10), cash and equivalents $5.2M (from $3.7M) and current portion of long‑term debt $0.8M (from $17.3M).American Shared Hospital Services Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
63
Positive
Cash Flow
41
Neutral
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 28.08M | 28.34M | 21.32M | 19.75M | 17.63M |
| Gross Profit | 5.04M | 9.19M | 9.34M | 8.38M | 6.73M |
| EBITDA | 3.70M | 8.91M | 6.97M | 8.44M | 6.97M |
| Net Income | -1.55M | 2.19M | 610.00K | 1.33M | 194.00K |
Balance Sheet | |||||
| Total Assets | 55.48M | 60.20M | 48.16M | 43.96M | 45.43M |
| Cash, Cash Equivalents and Short-Term Investments | 3.46M | 11.03M | 13.69M | 12.34M | 8.14M |
| Total Debt | 22.61M | 23.23M | 17.64M | 14.31M | 17.47M |
| Total Liabilities | 27.79M | 30.17M | 21.88M | 18.33M | 21.19M |
| Stockholders Equity | 24.03M | 25.18M | 22.62M | 21.63M | 19.89M |
Cash Flow | |||||
| Free Cash Flow | -4.54B | -7.77M | -555.00K | 6.85M | 4.59M |
| Operating Cash Flow | 3.10B | 167.00K | 5.72M | 7.24M | 6.27M |
| Investing Cash Flow | -7.63B | -7.11M | -6.27M | -388.00K | -1.67M |
| Financing Cash Flow | -3.03B | 4.41M | 1.91M | -2.66M | -655.00K |
American Shared Hospital Services Technical Analysis
Negative
2.10
Price Trends
1.60
Negative
1.87
Negative
2.09
Negative
Market Momentum
-0.06
Positive
38.63
Neutral
3.55
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Negative. The current price of 2.1 is above the 20-day moving average (MA) of 1.58, above the 50-day MA of 1.60, and above the 200-day MA of 2.09, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 38.63 is Neutral, neither overbought nor oversold. The STOCH value of 3.55 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMS.
American Shared Hospital Services Risk Analysis
American Shared Hospital Services disclosed 25 risk factors in its most recent earnings report. American Shared Hospital Services reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
American Shared Hospital Services Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $95.53M | 2.07 | 184.97% | ― | -0.87% | 10.51% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | $8.94M | -3.98 | -8.75% | ― | -0.62% | -200.79% | |
46 Neutral | $21.32M | -0.02 | ― | ― | 20.26% | 69.68% | |
46 Neutral | $27.87M | 145.34 | 15.82% | 11.14% | -2.56% | -2181.76% | |
44 Neutral | $62.28M | -1.05 | -88.97% | ― | -42.03% | -28904.55% |
* Healthcare Sector Average
AMS
American Shared Hospital Services
1.35
-1.02
-43.04%
CCM
Concord Medical Services
4.91
-2.14
-30.35%
CCEL
Cryo-Cell International
3.46
-1.37
-28.36%
DCGO
DocGo
0.63
-0.71
-52.99%
PIII
P3 Health Partners
13.20
5.94
81.82%
American Shared Hospital Services Corporate Events
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
American Shared Hospital Services Names Craig Tagawa Interim CEO
Neutral
Apr 24, 2026
On April 20, 2026, American Shared Hospital Services announced that Chief Executive Officer Gary Delanois resigned for personal reasons, effective April 24, 2026, marking a leadership change at the healthcare services provider. On April 23, 2026, ...
Business Operations and Strategy
American Shared Hospital Extends Proton Therapy Lease Agreement
Positive
Mar 19, 2026
American Shared Hospital Services has amended its long-standing Proton Beam Radiation Therapy Lease Agreement with Orlando Health, originally executed in 2006 and previously modified in 2012. On March 13, 2026, the parties agreed to extend the lea...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.